Medicine
Value of Inhaled Nitric Oxide in Acute Respiratory Distress Syndrome
Quick fact
Inhaled nitric oxide improves oxygenation in ARDS but has not been shown to reduce mortality, so it is reserved for short-term rescue in refractory hypoxemia.
Why this is interesting
In acute respiratory distress syndrome (ARDS), a treatment can improve a patient's oxygen levels yet not improve their chance of survival—how can that be?
Read the full explanation
Understanding Value of Inhaled Nitric Oxide in Acute Respiratory Distress Syndrome
Imagine the lungs as a crowded airport with gates (airways) and passengers (blood flow). In ARDS, many gates are closed (collapsed air sacs), so planes must divert to the few open gates. Nitric oxide when inhaled is a signal that says 'open this gate' but only reaches the gates that have airflow (ventilated regions). It causes blood vessels in those areas to widen, pulling more blood (passengers) to areas where oxygen exchange is possible. This improves the overall oxygen level in the blood. However, this improvement is temporary and does not address the underlying inflammation and damage, which is why it does not change long-term outcomes.
A deeper explanation
The value of inhaled nitric oxide (iNO) lies in its selective action. When delivered as a gas, it reaches only the alveoli that are well ventilated. There, it diffuses into the smooth muscle of adjacent pulmonary arterioles, activating soluble guanylate cyclase, which increases cyclic GMP and causes vasodilation. This redistributes pulmonary blood flow from unventilated regions (where it is wasted) to well-ventilated regions, thereby improving ventilation-perfusion matching and arterial oxygenation. The effect is rapid and reversible. Despite consistent improvements in oxygenation metrics, randomized controlled trials have failed to show a mortality benefit, likely because the underlying inflammatory injury and multi-organ dysfunction drive outcomes. Therefore, iNO is not recommended as routine therapy but may be used as a temporary bridge to more definitive strategies like ECMO.